Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |